Gene enhancement

NegotiableUpdate on 03/04

Model

Nature of the Manufacturer: Producers

Product Category

Place of Origin

Online Consult

Overview

Gene enhancement refers to the process of increasing gene expression levels or enhancing gene function through specific mechanisms, typically involving the regulation of enhancer sequences, transcriptional activators, or epigenetic modifications. Enhancers are a type of DNA sequence that can remotely promote gene transcription, significantly increasing the expression efficiency of target genes by binding to transcription factors. It plays an important role in cell development, tissue-specific expression, and disease occurrence, and is also a key regulatory tool in genetic engineering and gene therapy.

Product Details

1Gene enhancementDefinition and Core Features

Gene enhancementIt is a type of non coding DNA sequence that can remotely and efficiently activate gene transcription, and its core characteristics include:

Location flexibility: It can be located upstream/downstream/in introns of genes, with a distance of Mb from the target gene (such as SV40 enhancer remotely activating β - globin genes).
Direction independent: It can function in both positive and negative directions.
Efficiency: Increases the transcription efficiency of target genes by more than 100 times (such as a typical enhancer length of about 200 bp).
Cell type specificity: Activate different target genes in different cells/tissues (such as brain specific enhancers regulating neuronal development).

Terminology analysis：

Gene increase qGene Enhancement: Broadly refers to the mechanism that enhances gene expression efficiency, often specifically referring to enhancer effects.

Gene amplification: The replication of specific chromosomal regions leads to an increase in gene copy number, which is fundamentally different from enhancer regulation.

2、 Molecular mechanism: transcriptional activation in three-dimensional space

（1） Core model of enhancer promoter interaction

model	mechanism of action	Experimental evidence
Chromatin cyclization	Enhancers and promoters form a spatial loop through CTCF/adhesive proteins, which are physically close to each other (Looping)	Hi-C technology captures the three-dimensional conformation of chromatin
Sliding diffusion	Transcription factors that bind enhancers slide along DNA to the promoter region	Single molecule imaging verification
Relay activation	Multiple enhancers in series transmit activation signals	Research on the Regulation of Developmental Genes in Drosophila

（2） Molecular basis of enhancer activated transcription

Transcription factor recruitment：

Enhancer containingTranscription factor binding motif(such as ZNF410 motif cluster), recruit specific TFs (such as GATA1).
TF recruits through activation domains (such as VP64)Mediator complexMediate RNA polymerase II assembly.

Epigenetic modification：

Enrichment of enhancer regionsH3K27ac、H3K4me1Wait for activation markers and open chromatin (detectable by ATAC seq).
Histone modifying enzymes (such as p300) catalyze acetylation and release chromatin compression.

Super Enhancer：

Multiple enhancers tightly clustered (>3 kb), enriched with high-density TFs and mediators, strongly drivenCellular identity genes(such as stem cell pluripotency genes).

Example of dynamic regulation：
Low phosphorus stress → PHR transcription factor binding to rice enhancer → activation of phosphorus transporter gene → root structure adjustment [[data not directly cited, based on gene activation logic deduction]].

3、 Hierarchical network of enhancer functions

（1） Hierarchical regulatory architecture

hierarchy	Composition and Function	Biological significance
Basic enhancer	A single enhancer unit containing a small number of TF binding sites	Fine tune gene expression
Hub enhancer	Hub Enhancer that integrates multiple signals to regulate gene cluster expression	Coordinated developmental programs (such as somatic differentiation)
Super enhancer	Large span enhancer clusters (>10 kb) recruit ultra-high concentrations of TF and mediators	Maintain cellular identity (such as B cell characteristics)

（2） Characteristics of networked regulation

RedundancyMultiple enhancers jointly regulate the same gene (such as the mouse Shh gene being regulated by 9 enhancers).
synergyHomologous motifs (such as the ZNF410 cluster) enhance activation efficiency through synergistic effects (CHD4 enhancer mechanism).
noise resistanceWhen some enhancers are missing, the network can maintain gene expression stability.

4、 Enhancer identification and functional research techniques

（1） High throughput screening technology

technology	Principles and advantages	Application scenarios
STARR-seq	Inserting candidate DNA fragments downstream of the reporter gene to directly quantify enhancer activity	Whole genome enhancer map of fruit flies
scATAC-seq	Single cell level detection of chromatin openness and identification of cell type specific enhancers	Human Cell Atlas Project
CUT&Tag	High resolution localization of histone modifications and TF binding sites	Analysis of epigenetic markers for super enhancers

（2） Functional verification technology

CRISPR activation/inhibition：

DCas9-VP64 targets the activation enhancer, while dCas9 KRAB inhibits its function.

Enhancer deletion/mutation：

Knocking out the enhancer core sequence of CRISPR and observing changes in gene expression (such as in mouse embryonic models).

Database resources:

VISTA Enhancer Browser: A validated database of developmental enhancers.

SEdb: Super enhancer annotation platform.

5、 The significance of enhancers in diseases and treatments

（1） Disease mechanism

Disease type	Enhancer anomaly mechanism	target gene	consequence
cancer	Reconstruction of super enhancers near oncogenes (such as MYC)	Proliferative gene	Uncontrolled proliferation of cells
autoimmune disease	immunityGene increase qOverly open sub (such as IL6)	inflammatory factors	tissue damage
Developmental disorders	Neurodevelopmental enhancer mutation (FOXP2 enhancer)	Neuron migration genes	Language dysfunction

（2） Treatment strategy

Enhancer inhibition therapy：

BET inhibitor (JQ1) blocks the super enhancer binding protein and treats leukemia.

Enhancer editing：

CRISPR-dCas9 targets methylated pathogenic enhancers (such as tumor associated enhancers).

Design of synthetic enhancers：

Artificially constructing tissue-specific enhancers to drive gene expression therapy (such as CAR-T cell therapy).